Kafrelsheikh University

🇪🇬Egypt

Country: 🇪🇬Egypt

Ownership: Private

Employees: -

Market Cap: -

Website: http://kfs.edu.eg

Clinical Trials

Combining Aspirin With Ticagrelor or Cilostazol in Large-vessel Minor Stroke or TIA

Phase 3

Recruiting

Conditions: Ischemic Stroke

Interventions: Drug: Ticagrelor 90 MG
Drug: Cilostazol 100 MG

First Posted Date: 2024-09-11

Last Posted Date: 2024-09-11

Lead Sponsor: Kafrelsheikh University

Target Recruit Count: 900

Registration Number: NCT06591377

Locations: 🇪🇬
Kafr Elsheikh University Hospital, Kafr Ash Shaykh, Egypt

Combining Aspirin With Cilostazol or Clopidogrel in Large-vessel Minor Stroke or TIA

Phase 3

Recruiting

Conditions: Ischemic Stroke

Interventions: Drug: Cilostazol 100 MG
Drug: Clopidogrel

First Posted Date: 2024-09-11

Last Posted Date: 2024-09-11

Lead Sponsor: Kafrelsheikh University

Target Recruit Count: 870

Registration Number: NCT06591351

Locations: 🇪🇬
Kafr Elsheikh University Hospital, Kafr Ash Shaykh, Egypt

Effect of Sodium Glucose Co-tansporter 2 Inhibitors (SGLT2I) on Inflammatory and Oxidative Stress Markers Level in Heart Failure Patients

Recruiting

Conditions: Heart Failure

Interventions: Device: echo cardiogram
Drug: SGLT2 inhibitor

First Posted Date: 2024-09-05

Last Posted Date: 2024-09-05

Lead Sponsor: Kafrelsheikh University

Target Recruit Count: 60

Registration Number: NCT06585761

Locations: 🇪🇬
Kafrelsheikh University Hospital, Kafr Ash Shaykh, Egypt

Ticagrelor Versus Cilostazol in Ischemic Stroke

Phase 3

Recruiting

Conditions: Ischemic Stroke

Interventions: Drug: Ticagrelor 90 MG
Drug: Cilostazol 100 MG

First Posted Date: 2024-08-20

Last Posted Date: 2024-08-20

Lead Sponsor: Kafrelsheikh University

Target Recruit Count: 900

Registration Number: NCT06561867

Locations: 🇪🇬
Kafr Elsheikh University Hospital, Kafr Ash Shaykh, Egypt

Dabigatran Versus Apixaban in Cerebral Venous Thrombosis

Phase 3

Recruiting

Conditions: Cerebral Venous Sinus Thrombosis

Interventions: Drug: Dabigatran Etexilate 150mg
Drug: Apixaban 5MG

First Posted Date: 2024-08-13

Last Posted Date: 2024-08-13

Lead Sponsor: Kafrelsheikh University

Target Recruit Count: 200

Registration Number: NCT06551415

Locations: 🇪🇬
Kafr Elsheikh University Hospital, Kafr Ash Shaykh, Egypt

Dabigatran Versus Rivaroxaban in Cerebral Venous Thrombosis

Phase 3

Recruiting

Conditions: Cerebral Venous Sinus Thrombosis

Interventions: Drug: Dabigatran Etexilate 150mg
Drug: Rivaroxaban 20 MG Oral Tablet

First Posted Date: 2024-08-13

Last Posted Date: 2024-08-13

Lead Sponsor: Kafrelsheikh University

Target Recruit Count: 200

Registration Number: NCT06551402

Locations: 🇪🇬
Kafr Elsheikh University Hospital, Kafr Ash Shaykh, Egypt

Rivaroxaban Versus Apixaban in Cerebral Venous Thrombosis

Phase 3

Recruiting

Conditions: Cerebral Venous Thrombosis

Interventions: Drug: Rivaroxaban 20 MG Oral Tablet
Drug: Apixaban 5MG

First Posted Date: 2024-07-31

Last Posted Date: 2024-08-19

Lead Sponsor: Kafrelsheikh University

Target Recruit Count: 200

Registration Number: NCT06531122

Locations: 🇪🇬
Kafr Elsheikh University Hospital, Kafr Ash Shaykh, Egypt

Impact of Combined Oral Contraceptive Pills on Migraine

Phase 4

Recruiting

Conditions: Migraine

Interventions: Drug: Combined oral contraceptive
Drug: Vaginal Ring

First Posted Date: 2024-07-19

Last Posted Date: 2024-10-09

Lead Sponsor: Kafrelsheikh University

Target Recruit Count: 400

Registration Number: NCT06509503

Locations: 🇪🇬
Kafr Elsheikh University Hospital, Kafr Ash Shaykh, Egypt

Varicocelectomy in Patients With Clinical Varicocele and Unexplained Infertility

Not Applicable

Recruiting

Conditions: Unexplained Infertility

Interventions: Procedure: Bilateral Subinguinal microscopic varicocelectomy

First Posted Date: 2024-07-09

Last Posted Date: 2024-07-09

Lead Sponsor: Kafrelsheikh University

Target Recruit Count: 80

Registration Number: NCT06491251

Locations: 🇪🇬
Kafrelsheikh University, Kafr Ash Shaykh, Egypt

Valproate Versus Propranolol in Migraine

Phase 4

Recruiting

Conditions: Migraine Disorders

Interventions: Drug: Valproic Acid 500 MG
Drug: Propranolol

First Posted Date: 2024-07-03

Last Posted Date: 2024-07-03

Lead Sponsor: Kafrelsheikh University

Target Recruit Count: 600

Registration Number: NCT06485726

Locations: 🇪🇬
Kafr Elsheikh University Hospital, Kafr Ash Shaykh, Egypt

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy